Report of Foreign Issuer (6-k)
24 December 2019 - 12:30AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
December 23, 2019
001-36686
(Commission file number)
Forward Pharma A/S
(Translation of registrant’s name
into English)
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
(Address of principal executive office)
________________________________________
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes [ ] No [ X ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes [ ] No [ X ]
Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934. Yes [ ] No [ X ]
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): N/A
Item 1. Other Items
On December 20, 2019, Forward Pharma A/S (the “Company”)
received a written notice from the Nasdaq Stock Market (“Nasdaq”) indicating that the Company had regained compliance
with Nasdaq Listing Rule 5550(a)(2), which requires that the Company maintain a minimum bid price of $1.00 per share.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Date: December 23, 2019
|
|
|
|
Forward Pharma A/S
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Claus Bo Svendsen
|
|
|
|
|
|
|
Name: Claus Bo Svendsen
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Forward Pharma AS (NASDAQ): 0 recent articles
More Forward Pharma A/s News Articles